Long-term maintenance of vision required to drive in patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) following anti-VEGF intravitreal therapy (IVT)

被引:0
|
作者
Emami-Naeini, Parisa [1 ]
Boucher, Nicholas [2 ]
Fernando, Rusirini [2 ]
Menezes, Alicia [3 ]
Garmo, Vincent [3 ]
机构
[1] Univ Calif Davis, Ophthalmol, Davis, CA 95616 USA
[2] Vestrum Hlth, Ottawa, ON, Canada
[3] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3516
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Peripapillary and macular microvasculature in neovascular age-related macular degeneration in long-term and recently started anti-VEGF therapy versus healthy controls
    Tuerksever, Cengiz
    Hoffmann, Laura
    Hatz, Katja
    FRONTIERS IN MEDICINE, 2023, 9
  • [32] Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
    Corazza, Paolo
    D'Alterio, Francesco Maria
    Kabbani, Jamil
    Alam, Mostafa Mohamed Ragheb
    Mercuri, Stefano
    Orlans, Harry Otway
    Younis, Saad
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [33] Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
    Paolo Corazza
    Francesco Maria D’Alterio
    Jamil Kabbani
    Mostafa Mohamed Ragheb Alam
    Stefano Mercuri
    Harry Otway Orlans
    Saad Younis
    BMC Ophthalmology, 21
  • [34] Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration
    Maiko Inoue
    Kazuaki Kadonosono
    Akira Arakawa
    Shin Yamane
    Tatsuro Ishibashi
    Japanese Journal of Ophthalmology, 2015, 59 : 173 - 178
  • [35] ANTI-VEGF COST CALCULATOR IN WET AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA IN PORTUGAL
    Valente, C.
    Graca, A.
    Barreiras, I
    Monteiro, M. J.
    Andre, S.
    VALUE IN HEALTH, 2022, 25 (12) : S165 - S165
  • [36] Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) in Routine Clinical Practice
    Pitcher, John D.
    Moshfeghi, Andrew A.
    Lucas, Genevieve
    Boucher, Nick
    Saroj, Namrata
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [37] Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration
    Inoue, Maiko
    Kadonosono, Kazuaki
    Arakawa, Akira
    Yamane, Shin
    Ishibashi, Tatsuro
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2015, 59 (03) : 173 - 178
  • [38] Long-term changes in retinal layers in patients undergoing intravitreal ranibizumab for neovascular age-related macular degeneration: Retinal layers after anti-VEGF therapy
    Inan, Umit Ubeyt
    Baysal, Zeki
    Inan, Sibel
    INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (12) : 2721 - 2730
  • [39] INTRAOCULAR INFLAMMATION FOLLOWING INTRAVITREAL FARICIMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD)
    Punit, Ankita Abhinandan
    Hasan, Hani
    Da Costa, Joanna
    EYE, 2024, 38 : 173 - 173
  • [40] ANTI-VEGF TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN AUSTRALIA
    Finger, Robert
    Fotis, Kathy
    Cummins, Rob
    Heraghty, Julie
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 14 - 14